Renovion
Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program
August 02, 2022 09:05 AM Eastern Daylight Time CHAPEL HILL, N.C.--(BUSINESS WIRE)--Renovion, Inc., a clinical-stage pharmaceutical...
Search
Renovion
- 2 min
Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF Bronchiectasis
Chapel Hill, NC, April 7, 2022 – Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare,...
Renovion
- 3 min
Marty Zamora, MD, joins Renovion, Inc. as Chief Medical Officer
CHAPEL HILL, North Carolina, April 12, 2022-- Renovion today announced that Dr. Martin “Marty” Zamora, MD, has joined Renovion as Chief...
Renovion
- 5 min
A breathe-easier breakthrough
Renovion, a UNC-affiliated startup, advances a breakthrough therapy to restore lung health and quality of life in patients with diseases...
Renovion
- 3 min
Exploristics signs collaboration agreement with Renovion, using the cloud-based simulation platform
Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform...
Renovion
- 3 min
Renovion and the COPD Foundation Launch COPD and Bronchiectasis Development Partnership to Address
Chapel Hill, NC and Miami, FL - Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the...
Renovion
- 2 min
Renovion Announces Addition of Rich Mattingly to Board of Directors
Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of chronic inflammatory lung diseases, announced the...
Renovion
- 2 min
Publication of Research Demonstrating the Impact of ARINA-1 on Mucus Transport in Cystic Fibrosis
CHAPEL HILL, N.C., July 9, 2020 -- Renovion, Inc., a biopharmaceutical company on a mission to transform the lives of patients with...
Renovion
- 3 min
Completion of $8.1 Million Financing Round Enabling Clinical Programs in Chronic Lung Diseases
Poised for pivotal lung transplant trial in U.S. CHAPEL HILL, N.C., June 18, 2020 /Businesswire/ -- Renovion, Inc., a biopharmaceutical...
Renovion
- 2 min
Dr. Robert Ryan joins Renovion, Inc. Board of Directors
CHAPEL HILL, N.C., March 1, 2018 -- Renovion, Inc., a privately-held biopharmaceutical company developing novel therapeutics for...
Renovion
- 2 min
Renovion Elects Derek Winstanly as Chairman of Board of Directors
December 20, 2017 09:00 AM Eastern Standard Time DURHAM, N.C.--(BUSINESS WIRE)--Renovion, Inc. ("Renovion"), an early stage drug...
Renovion
- 2 min
Renovion, Inc. Receives Orphan Designation for Arina-1 for the Treatment of Lung Dysfunction followi
Renovion, Inc. announced today that the FDA Office of Orphan Products has granted Orphan Designation in the US to the Company's nebulized...
Renovion
- 2 min
Chapel Hill startups represent in D.C.
Two Chapel Hill-based startups — EpiCypher and Renovion — attended the first University Startups Demo Day in Washington, D.C. CHAPEL...
Renovion
- 3 min
‘Spirit of innovation’
CHAPEL HILL, N.C., September 19, 2016. Of the more than 800 startups created at universities across the country this year, only 35 have...
Renovion
- 2 min
Entrepreneur with GSK roots targets lung transplant survival rates with UNC technology
In a tiny lab in Chapel Hill, a 3-year-old startup with UNC-Chapel Hill technology is trying to help lung transplant patients defy the...
Renovion
- 2 min
Renovion Receives Patent Allowance for Novel Therapy
- Patent claims set foundation for commercialization - Board and management team in place to execute pre-clinical plan CHAPEL HILL, N.C.,...